Sanofi Said to Plan Move Out of Paris Headquarters to Cut Costs
- Company said to discuss leaving rented site on rue La Boetie
- Legal setback on cholesterol drug adds to pressure on expenses
This article is for subscribers only.
Sanofi, France’s biggest drugmaker, is discussing a move out of its headquarters in central Paris as part of Chief Executive Officer Olivier Brandicourt’s push to save money, according to people familiar with the situation.
The company probably will move its headquarters to Gentilly, a town south of Paris where it already has offices, said the people, who asked not to be identified as the plans aren’t public. A transfer would help save several million euros, one person said. Sanofi has about 700 workers at its headquarters. A Sanofi spokesman declined to comment.